参考文献/References:
[1] Rajhbeharrysingh U, Taylor M, Milas M. Medical therapy for advanced forms of thyroid cancer[J]. Surg Clin North Am, 2014, 94(3): 541-571.
[2] Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995[J].Cancer, 1998, 83(12): 2638-2648.
[3] Mizushima N. Autophagy: process and function[J].Genes Dev, 2007, 21(22): 2861-2873.
[4] Kroeme G, Marino G, Levine B. Autophagy and the integrated stress response[J].Mol Cell, 2010, 40(2): 280-293.
[5] Ravikumar B, Sarkar S, Davies JE, et al. Regulation of mammalian autophagy in physiology and pathophysiology[J].Physiol Rev, 2010, 90(4): 1383-1435.
[6] White E,DiPaola RS.The double-edged sword of autophagy modulation in cancer[J].Clin Cancer Res, 2009, 15(17): 5308-5316.
[7] Li LC, Liu GD, Zhang XJ, et al. Autophagy, a novel target for chemotherapeutic intervention of thyroid cancer[J].Cancer Chemother Pharmacol, 2014, 73(3): 439-449.
[8] Kenific CM, Thorburn A, Debnath J. Autophagy and metastasis: another double-edged sword[J]. Curr Opin Cell Biol, 2010, 22(2): 241-245.
[9] Mathew R, Kongara S, Beaudoin B, et al. Autophagy suppresses tumor progression by limiting chromosomal instability[J]. Genes Dev, 2007, 21(11): 1367-1381.
[10] Robert T, Vanoli F, Chiolo I, et al. HDACs link the DNA damage response, processing of double-strand breaks and autophagy[J]. Nature, 2011, 471(7336): 74-79.
[11] Rodriguez-Rocha H, Garcia-Garcia A, Panayiotidis MI, et al. DNA damage and autophagy[J]. Mutat Res, 2011, 711(1-2): 158-166.
[12] Yue Z, Jin S, Yang C, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor[J].Proc Natl Acad Sci U S A, 2003, 100(25): 15077-15082.
[13] Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors[J].Genes Dev,2011, 25(8): 795-800.
[14] Mathew R, Karp CM, Beaudoin B, et al. Autophagy suppresses tumorigenesis through elimination of p62[J].Cell,2009,137(6): 1062-1075.
[15] Degenhardt K, Mathew R, Beaudoin B, et al.Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis[J].Cancer Cell, 2006,10(1): 51-64.
[16] Li X, Xu H, Ma H. Beclin 1 is highly expressed in papillary thyroid carcinoma and correlates with lymph node metastasis[J]. Acta Chir Belg,2013,113(3):175-181.
[17] Zhang Y, Yang WQ, Zhu H,et al. Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin[J].Biochem Pharmacol,2014,87(4):562-570.
[18] Plantinga TS, van de Vosse E, Huijbers A, et al. Role of genetic variants of autophagy genes in susceptibility for non-medullary thyroid cancer and patients outcome[J].PLoS One, 2014,9(4): e94086.
[19] Lambert LA, Qiao N, Hunt KK, et al. Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model[J].Cancer Res,2008,68(19): 7966-7974.
[20] Lin CI, Whang EE, Abramson MA, et al. Autophagy: a new target for advanced papillary thyroid cancer therapy[J]. Surgery, 2009, 146(6): 1208-1214.
[21] Johnson BE, Jackman D,Janne PA. Rationale for a phase Ⅰ trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus(RAD001)for patients with relapsed non small cell lung cancer[J]. Clin Cancer Res, 2007, 13(15 Pt 2): s4628-s4631.
[22] Buytaert E, Callewaert G, Vandenheede JR, et al. Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum[J].Autophagy, 2006, 2(3): 238-240.
[23] Lu CH, Liu YW, Hua SC, et al. Autophagy induction of reversine on human follicular thyroid cancer cells[J].Biomed Pharmacother, 2012, 66(8): 642-647.
[24] Lin CI, Whang EE, Lorch JH, et al. Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer[J].Surgery, 2012, 152(6): 1142-1149.
[25] Chen N, Karantza V.Autophagy as a therapeutic target in cancer[J].Cancer Biol Ther, 2011, 11(2): 157-168.
[26] Yang ZJ, Chee CE,Huang S,et al. The role of autophagy in cancer: therapeutic implications[J].Mol Cancer Ther,2011, 10(9): 1533-1541.
相似文献/References:
[1]于亚静 杨彩哲 关小宏 王良宸 吴石白 刘明 肖黎 张妲 刘朝阳.甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究[J].国际内分泌代谢杂志,2015,(01):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
Yu Yajing*,Yang Caizhe,Guan Xiaohong,et al.Relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors[J].International Journal of Endocrinology and Metabolism,2015,(01):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
[2]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(01):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[3]孟祥慧,徐书杭,蔡可英,等.肥胖与甲状腺癌：临床新启示[J].国际内分泌代谢杂志,2014,(02):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
Meng Xianghui*,Xu Shuhang,Cai Keying,et al.Obesity and thyroid cancer: a new clinical implication[J].International Journal of Endocrinology and Metabolism,2014,(01):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
[4]孙洪平,陈国芳,曹雯,等.糖尿病与甲状腺癌关系的研究进展[J].国际内分泌代谢杂志,2014,(02):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
Sun Hongping,Chen Guofang,Cao Wen,et al.Diabetes and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2014,(01):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
[5]于亚静,杨彩哲,关小宏,等.桥本甲状腺炎和甲状腺癌的关系[J].国际内分泌代谢杂志,2014,(03):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]
Yu Yajing,Yang Caizhe,Guan Xiaohong,et al.Relationship between Hashimoto's thyroiditis and thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2014,(01):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]
[6]冯俊杰,戴阳丽,王秀敏.MIN6细胞系的细胞学特性及其应用[J].国际内分泌代谢杂志,2016,36(02):135.[doi:10.3760/cma.j.issn.1673-4157.2016.02.014]
Feng Junjie,Dai Yangli,Wang Xiumin..Cytological characteristics and application of MIN6 cell line[J].International Journal of Endocrinology and Metabolism,2016,36(01):135.[doi:10.3760/cma.j.issn.1673-4157.2016.02.014]
[7]张洁,邸阜生.运动防治非酒精性脂肪性肝病的机制[J].国际内分泌代谢杂志,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
Zhang Jie,Di Fusheng..Mechanism of exercise on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2016,36(01):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
[8]方钱华,李春君.足细胞自噬与糖尿病肾病[J].国际内分泌代谢杂志,2017,37(04):242.
Fang Qianhua,Li Chunjun..Relationship of podocyte autophagy and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2017,37(01):242.
[9]张倍宁 闫如意 周金莲 崔彦.甲状腺癌中miRNA的表达及作用[J].国际内分泌代谢杂志,2018,38(03):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
Zhang Beining*,Yan Ruyi,Zhou Jinlian,et al.Expression and function of miRNA in thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2018,38(01):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
[10]金启辉 韩春茂.内皮细胞自噬在糖尿病血管病变中的作用[J].国际内分泌代谢杂志,2018,38(02):113.[doi:10.3760/cma.j.issn.1673-4157.2018.02.011]
Jin Qihui,Han Chunmao.The role of autophagy of endothelial cells in diabetic vascular diseases[J].International Journal of Endocrinology and Metabolism,2018,38(01):113.[doi:10.3760/cma.j.issn.1673-4157.2018.02.011]